| Indication (%) | Number of hip |
| Primitive coxarthrose (4.26%) | 2 |
| Secondary coxarthrose |
|
| -Coxarthrose post-traumatic (14.89%) | 7 |
| -Coxarthrose on congenital dysplasia (10.64%) | 5 |
| § The sequelae of LCH (8.51%) | 4 |
| § Cotyloïdienne dysplasia (2.13%) | 1 |
| -sequelae of primitive osteochondrite of the Hip (OPH) (2.13%) | 1 |
| -sequelae of epiphysiolyse (2.13%) | 1 |
| -The sequelae of coxite tuberculous infectious (6.38%) | 3 |
| -Aseptic osteonecrosis of the femoral head (ONATF) (31.91%) | 15 |
| § Post-traumatic stress disorder (12.77%) | 6 |
| § Secondary to a corticosteroid (2.13%) | 1 |
| § Secondary to an ethylisme (2.13%) | 1 |
| § The idiopathic (14.89%) | 7 |
| -Patella tendon inflammation of the femoral neck (2.13%) | 1 |
| -Other: | 1 |
| § Neurogenic Paraosteoarthropathie (NENA) (2.13%) |
|
| -Coxites inflammatory (23.40 %) | 11 |
| § Rheumatoid arthritis (PR) (10.64%) | 5 |
| § Ankylosing spondylitis (SPA) (12.76%) | 6 |